Detection of BRAF splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapies

The analysis of plasma circulating tumour nucleic acids provides a non-invasive approach to assess disease burden and the genetic evolution of tumours in response to therapy. BRAF splicing variants are known to confer melanoma resistance to BRAF inhibitors. We developed a test to screen cell-free RN...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Michael E., Rizos, Helen, Pereira, Michelle R., McEvoy, Ashleigh C., Marsavela, Gabriela, Calapre, Leslie, Meehan, Katie, Ruhen, Olivia, Khattak, Muhammad A., Meniawy, Tarek M., Long, Georgina V., Carlino, Matteo S., Menzies, Alexander M., Millward, Michael, Ziman, Melanie, Gray, Elin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646833/
https://www.ncbi.nlm.nih.gov/pubmed/33216826
http://dx.doi.org/10.18632/oncotarget.27790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646833/
https://www.ncbi.nlm.nih.gov/pubmed/33216826
http://dx.doi.org/10.18632/oncotarget.27790

Ejemplares similares